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Induction of polyphosphoinositide hydrolysis in cardiac tissue by specific recognition of class I histocompatibility anti- 
gens was assayed. C3H (H-2 k) mice auricles were labelled with myo-pH]inositol precursor and inositol phosphate produc- 
tion in the presence or absence of anti-class I k products was measured. Anti-class I, but not anti-class II products pecifi- 
cally increased phosphoinositide turnover. This increment was partially blocked by muscarinic cholinergic and ct-adrener- 
gic blockers and even more so by the phospholipase C inhibitor NCDC. Alloantibodies specifically directed against class 
I antigens could then exert stimulation of phospholipase C-mediated phosphoinositide hydrolysis through the interaction 
with muscarinic holinergic and/or ~-adrenergic receptors. The induction of intraceUular second messengers by class I 
antigens and hormone-receptor interactions is discussed. 
Histocompatibility antigen; Alloantibody; Phosphoinositide turnover; Phospholipase C; Adrenergic receptor, ~-; 
Muscarinic holinergic receptor 
1. INTRODUCTION 
Hormones, neurotransmitters and a wide variety 
of growth-promoting factors exert heir physiologi- 
cal responses through intracellular signals induced 
by their interactions with specific cell surface re- 
ceptors. In addition to receptors that regulate cy- 
clic AMP (cAMP) formation, there is another type 
of cell surface receptor which stimulates phospho- 
lipase C-mediated hydrolysis of phosphatidyl- 
inositol 4,5-bisphosphate (PIP2) into inositol 
1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol 
(DG) [1]. Muscarinic holinergic and al-adrenergic 
receptors of the heart are coupled to stimulated 
polyphosphoinositide turnover [2,3] and it has 
been suggested that some of the physiological and 
metabolic effects of adrenergic and cholinergic ac- 
tions upon myocardium are secondary to receptor- 
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mediated hydrolysis of phosphoinositides [1,3]. 
Furthermore, it has been demonstrated that the 
products of phospholipase C hydrolysis, namely 
DG and PI3, may serve as intracellular second mes- 
sengers. On the other hand, it was recently reported 
that major histocompatibility (HC) antigens (Ag), 
especially class I molecules, play an important role 
in some ligand-receptor interactions [4,5], includ- 
ing insulin [6-9], epidermal growth factor, luteiniz- 
ing hormone [11] and 13-adrenergic receptors 
[11-14]. In the last case our group demonstrated 
that alloimmune anti-class I serum activation of 
cardiac fll-adrenoceptors leads to intracellular sig- 
naling by increasing cAMP production [14]. Our 
purpose was the investigation of whether alloanti- 
body action was restricted to cAMP production or 
if other intracellular signals, i.e. phospholipase C 
product formation, could also be stimulated. Here 
we show that alloimmune antibody, while specifi- 
cally recognizing class I molecules of cardiac tissue, 
activates phosphoinositide turnover through 
muscarinic holinergic and/or tr-adrenergic recep- 
tor interactions. 
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2. MATERIALS AND METHODS 
2.1. Materials 
myo-[2-3H]Inositol ([3H]MI) precursor (S= 15 Ci/mmol) 
was from New England Nuclear. Bio-Rad AG I-X8 (100-200 
mesh, formate form) anion-exchange resin was used. Methox- 
amine (Met) was from Burrough's Wellcome; phentolamine 
(Phent) from Ciba; carbachol, atropine and 2-nitro-4-carboxy- 
phenyl-N,N-diphenylcarbamate (NCDC) from Sigma. Other 
chemicals used were of analytical grade. For chromatographic 
procedures the following standards from Sigma were used: myo- 
inositol 2-monophosphate, D-myo-inositol bisphosphate, D- 
myo-inositol trisphosphate, DL-myo-inositol 1-monophos- 
phate, DL-myo-inositol 2-monophosphate and DL-myo- 
inositol 1,2-cyclic monophosphate. Alloimmune mouse anti- 
serum against H-2 k HC Ag was obtained by immunizing 
BALB/c (H-2 d) mice with C3H (H-2 k) lymphoid cells as describ- 
ed [12,14]. Subsequent purification of alloimmune IgG was 
achieved by DEAE-cellulose ion-exchange chromatography and 
the degree of purification was determined by immunoelectro- 
phoresis as in [12]. Monoclonal anti-class I k aUoantigens, 3.83 
(K k, Dk), were kindly supplied by Dr K. Ozato (Laboratory of 
Developmental nd Molecular Immunity, National Institute of 
Child Health and Human Development, National Institutes of 
Health, Bethesda, MD). Monoclonal anti-class II alloantigens 
of k haplotypes were I-E k (Ia.7) from Cedarlane, specific for Ia 
Ag coded by the E subregion of the k hapletype. 
2.2. Incubation 
Adult C3H mice were killed by decapitation and atrial appen- 
dages (nearly 10 mg wet wt) were rapidly excised after allowing 
hearts to beat in modified Krebs-Ringer-bicarbonate (KRB) 
solution, gassed with 5°70 CO2 in 02, in order to expel all remain- 
ing blood. The ionic composition of KRB was reported in [15]. 
Auricles were transferred to continuously oxygenated vessels 
containing 0.5 ml buffer with 1/zCi [3H]MI, and 10 mM LiCI 
was added for inositol monophosphate accumulation, accor- 
ding to Berridge t al. [16]. Atrial preparations were incubated 
at 37°C in a shaking water bath for 120 min. Alloantibody or 
agonists were added 30 min before the end of the incubation pe- 
riod. When blockers were used, they were added 30 min before 
addition of alloantibody. 
2.3. Total labelled inositol phosphate (IP) measurement 
After incubation, water-soluble IPs were extracted following 
Berridge t al. [16]. Briefly, auricles were quickly washed with 
KRB and homogenized in 0.3 ml KRB with 10 mM LiC1 and 
2 rnl chloroform/methanol (1:2, v/v), for stopping incubation 
reactions. Chloroform (0.62 ml) and water (1 ml to separate 
phases) were then added. Samples were centrifuged at 2000 x g 
for 15 min and the upper aqueous phase (- 1.8 ml) was applied 
to a 0.7 ml column of Bio-Rad AG-X8 suspended in 0.1 M for- 
mic acid and previously washed with 10 mM Tris-formate (pH 
7.4). The resin was then washed with 20 vols of 5 mM myo- 
inositol followed by 6 vols water and IPs were eluted with 1 M 
ammonium formate in 0.1 M formic acid. Fractions of 1 ml 
were recovered and the radioactivity determined by scintillation 
counting. Results were expressed as the percentage of control 
peak areas which were determined by triangulation. 
2.4. Chromatography of radiolabelled compounds 
In order to determine the absence of [3H]MI in the IP eluted 
peak, chromatography on silica gel 60 F254 sheets (Merck) was 
performed using propan-2-ol/6 N NH4OH (14 : 5) as developing 
solvent [17]. Spots were located by spraying with freshly 
prepared 0.1 070 FeCI3 in ethanol, followed, after air-drying, with 
1070 sulfosalicylic acid in ethanol, as described by Hokin- 
Neaverson and Sadeghian [17]. To determine radioactivity, a 
histogram was constructed from cutting up of the sheet gel, 
placing each sample in Triton-toluene-based scintillation fluid 
and counting. 
3. RESULTS 
In order to analyze alloantibody actions on 
phosph01ipase C-induced intracellular second mes- 
sengers in cardiac tissue, C3H auricles were in- 
cubated with radiolabelled MI precursor in the 
presence of 10 mM LiC1 and water-soluble IPs 
formed in the presence and absence of alloimmune 
BALB/c anti-C3H IgG were subjected to anion- 
exchange chromatography. We gathered fractions 
corresponding to 5 mM myo-inositol washing (first 
peak) that contains remaining [3H]MI, and 1 M 
ammonium formate elution (second peak) that 
contains total IPs, namely IP3, inositol bisphos- 
phates (IPz), with particular accumulation of in- 
ositol monophosphates (IP) as described before 
[16,18] (see fig. 1A). Alloimmune BALB anti-C3H 
IgG was capable of producing a 2.0-fold increase in 
the second peak without modifications of the first 
one (fig.lA,B). This pointed to the fact that allo- 
antibody increased cardiac PI turnover, since it 
could augment IP formation without affecting in- 
corporation of [3H]MI into the tissue. It should be 
noted that normal IgG (obtained from BALB/c 
mice injected with saline) gave results similar to 
those of controls (not shown). 
In order to ensure that the 2nd peak did not con- 
tain contaminating [3H]MI, we analyzed control 
and alloimmune antibody produced peaks by 
chromatography using MI, [3H]MI, IP3, IP2 and 
distinct IP [inositol 1-monophosphate (I-l-P), ino- 
sitol 2-monophosphate (I-2-P) and inositol 1,2-cy- 
clic monophosphate (clP)] as standards. As shown 
in fig.2, the products in the first peak remain at the 
origin and those of the 2nd peak gave a spot with 
the same Rf value as that of clP. When the radioac- 
tivity in the chromatograms was evaluated, it was 
observed (see histogram bars; fig.2) that [3H]MI re- 
mained at the origin and that the radioactivity run 
with the spot of the 2nd peak only when IPs were 
used as carrier. 
In order to investigate the participation of hor- 
303 






H~O i HCO(~IH& 
B 
0 ~  










Volume 249, number 2 FEBS LETTERS June 1989 
// 
Met [gGi Atrop. Phent Prop. NCDC 
÷ ~+G + ÷ lgGz I t lgGz lgG1 
Fig. 1. Alloantibody effect on formation of  IPs. Action of different hormone receptor blockers. C3H mouse atria were incubated for 
60 min with [3H]MI and for an additional 30 min in the absence or presence of  different hormone receptor blockers [10 -6 M atropine 
(Atrop.), 10 -6 M phentolamine (Phent.), 5 × 10 -7  M propranolol (Prop.)[ or a phospholipase C inhibitor (5 × 10 -6 M NCDC). Tissues 
were then left for a further 30 rain in the presence or absence of  BALB/c anti-C3H IgG or in the presence of hormone receptor agonists 
[5 x 10 -4 M carbachol (Curb.) or 10 -4 M methoxamine (Met.)]. (A) Anion-exchange chromatography of [3H]MI and its derived 
radiolabelled products, obtained in the presence (O---O) or absence (e - - -e )  of alloantibody. Peaks eluting with 5 mM myo-inositol 
(first peak) and with 1 M ammonium formate (second peak) are displayed. (B) Formation of IPs was analyzed in the presence of the 
indicated rugs. Values represent the amount of radioactivity, for each experimental condition, as percentage of control. Each set of 
data is the mean of 3 independent experiments + SE. * p<0.001 vs control and ** p<0.001 vs IgGi alone, by one-way analysis of 
variance and the Dunnett est. 
mone receptors in the phenomenon, the actions of 
the alloantibodies were assayed in the presence of 
muscarinic holinergic and tz-adrenergic blockers. 
Since we had previously observed alloantibody- 
induced/~-adrenergic eceptor activation i  cardiac 
tissue, we also analyzed the effect of the g-blocker 
propranolol, in order to exclude any indirect un- 
known action of g-adrenergic activation upon 
stimulation of phosphoinositide hydrolysis. As 
seen in fig.lB, 5 x 10 -7  M propranolol did not af- 
fect alloantibody action upon stimulation of PI 
turnover, but is was significantly diminished by 
10 -6 M atropine and 10 -4 M phentolamine, point- 
ing to the fact that muscarinic holinergic and a- 
adrenergic receptor interactions with alloantibody 
are responsible for the increase in PI turnover. Fur- 
thermore, 5 × 10 -6 M NCDC, a phospholipase C 
inhibitor, also abrogated the effect of alloimmune 
IgG on PI turnover, indicating that phospholipase 
C-mediated hydrolysis of PIP2 is involved in the 
phenomenon. Alloantibody action was also com- 
pared with that of cr-adrenergic and muscarinic 
cholinergic agonists. In fig.lB, it is shown that 
alloimmune IgG mimics the effect of 5 × 10 -6 M 
carbachol, but was less than that of 10-4M 
methoxamine. High doses of cr-agonist were used, 
since these were previously reported [18] to be ef- 
fective in inducing contractile ffects on a murine 
cardiac isolated preparation. 
To demonstrate the marked specificity of alloim- 
mune antibody in exerting these effects on phos- 
phoinositide turnover, its action was assayed on an 
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Fig.2. Silica gel sheet ascending chromatographic analysis of 
peaks eluted on anion-exchange chromatography. Propan-2-ol/ 
6 N NH4OH (14:5) was used as developing solvent for as- 
cending chromatography performed as described in section 2. 
All compounds were applied in 10/~g amounts. [3H]MI was 
diluted 100-times and 2/zl were applied using unlabelled myo- 
inositol (MI) as carrier. For 1 st and 2nd peaks, aliquots of 200/zl 
were separated prior to scintillation counting of eluted frac- 
tions, and those with the greatest amount of radioactivity were 
chosen for chromatographic analysis. Where indicated the 2nd 
peak products were applied using MI or a pool of inositol 
monophosphate (IP) as carriers. The following standards were 
used: inositol bisphosphate (IP2), inositol trisphosphate (IP~), 
inositol 1,2-cyclic monophosphate (clP), inositol -monophos- 
phate (I-I-P) and inositol 2-monophosphate (I-2-P). The his- 
tograms how serial 1 cm strip counting of the radioactivity 
from radiolabelled standard MI, 1st and 2nd peaks. S.F., sol- 
vent front; O, origin. 
Table 1 
Class I AG participation i  alloantibody-induced stimulation of 
PI turnover 
Alloantibody Atria IP formation 
(% of control) 
BALB/c anti-C3H IgG C3H 92 :!: 9 a 
BALB/c 1.1 + 5 
Mo 3.83 C3H 91 _+ 8 a 
Mo Ia.7 C3H 2.0 + 3 
a Differs significantly from control, with p < 0.001, by one-way 
analysis of variance and the Dunnett est 
Murine atria (C3H or BALB/c where indicated) were incubated 
in KRB with 1/~Ci [3H]MI and 10 mM LiCI for a total of 
120 rain as described. In the last 30 min of incubation, different 
alloantibodies were added: polyclonal BALB/c anti-C3H IgG, 
monoclonal nti-class I k alloantigens (Mo 3.83) or monoclonal 
anti-class II products of the k haplotype (Mo Ia.7). Water- 
soluble radiolabelled products were extracted and separated by 
anion-exchange chromatography as described in the text. Per- 
centage of IP formation with respect to controls was determined 
for each experimental condition. Results are means of 3 in- 
dependent experiments + SE 
unrelated cardiac BALB/c preparation, and mono- 
clonal antibodies specific to class I or II products 
were also used. As shown in table 1, BALB/c anti- 
C3H IgG has no effect upon formation of IPs in 
BALB/c cardiac tissue. Furthermore, only mono- 
clonal 3.83 directed to class I alloantigens showed 
the same action as that of polyclonal alloantibody, 
with anti-class II product antibody having no effect 
on IP formation. 
4. DISCUSSION 
Molecules of major histocompatibility complex 
class I interact with several hormone receptors and 
it has been proposed that this sort of association is 
required for triggering cell activation [11,14]. We 
had previously reported that cAMP formation in- 
duced by Z?-adrenoceptor-class I molecule interac- 
tions took place in cardiac tissue [14]. Therefore, 
these associations could produce transmembrane 
signalling necessary for the biological effects of 
hormones. Here, we report hat class I Ag specific 
recognition by alloantibody is able to stimulate for- 
mation of IPs via polyphosphoinositide hydrolysis, 
as the effects of alloimmune IgG were blunted by 
the phospholipase C inhibitor, NCDC. Hence, 
other intracellular second messengers are capable 
of being activated by class I product-hormone re-
ceptor interactions. In this case, the receptors that 
participate appear to be cardiac muscarinic 
cholinergic and cr-adrenergic receptors, since the 
effect of alloantibody upon IP formation was sig- 
nificantly diminished by atropine and phentol- 
amine, respectively. Others have previously dem- 
onstrated that some of the physiological nd meta- 
bolic effects of tr-adrenergic and cholinergic stimu- 
lation on myocardium are secondary to receptor- 
mediated hydrolysis of PI [18,20,21]. The reason 
why the action of alloantibody upon the formation 
of IPs could implicate that both types of receptor 
are involved, without distinguishing between the 
two, is uncertain, but it has been proposed that cr- 
adrenergic and cholinergic receptors are func- 
tionally associated on isolated murine atria [19]. 
Nevertheless, the present data support he idea 
that class I molecules and hormone receptors inter- 
act in the cell membrane, implicating perhaps the 
corresponding regulatory nucleotide-binding pro- 
teins. The physiological importance of this interac- 
tion is in need of further clarification. 
305 
Volume 249, number 2 FEBS LETTERS June 1989 
Acknowledgements: This work was supported by grant 
3904801/85 from CONICET. We thank Mrs Elvita Vannucchi 
for excellent technical assistance and Mrs Beatriz Costigliolo for 
secretarial ssistance. 
REFERENCES 
[1] Abdel-Latif, A.A. (1986) Pharmacol. Rev. 38,227-272. 
[2] Brown, J.H. and Brown Masters, S. (1984) Fed. Proc. 43, 
2613-2617. 
[3] Brown, J.H., Buxton, I.L. and Brunton, L.L. (1985) Circ. 
Res. 57,532-537. 
[4] Simons~a, M. and Olsson, L. (1983) Ann. Immun. Inst. 
Pasteur 134D, 85-92. 
[5] Edidin, M. (1983) Immun. Today 4, 269-270. 
[6] Chvatchko, Y., Van Obberghen, E., Kiger, N. and 
Fehlmann, M. (1983) FEBS Lett. 163, 207-211. 
[7] Fehlmann, M., Peyron, J.-F., Samson, M., Van 
Obberghen, E., Brandenburg, D. and Brossette, N. (1985) 
Proc. Natl. Acad. Sci. USA 82, 8634-8637. 
[8] Due, C., Simonsen, M. and Olsson, L. (1986) Proc. Natl. 
Acad. Sci. USA 83, 6007-6011. 
[9] Cousin, J.L., Samson, M., Pilch, P. and Fehlmann, M. 
(1987) Biochem. J. 242, 403-410. 
[10] Schreiber, A.B., Schlessinger, J. and Edidin, M. (1984) J. 
Cell Biol. 98, 725-731. 
[11] Solano, A.R., Cremaschi, G., Sanchez, M.L., Borda, E., 
Sterin-Borda, L. and Podestfi, E.J. (1988) Proc. Natl. 
Acad. Sci. USA 85, 5087-5091. 
[12] Cremaschi, G.A., Sterin-Borda, L., Genaro, A.M., 
Borda, E.S. and Braun, M. (1984) J. Immunol. 133, 
2681-2685. 
[13] Sterin-Borda, L., Cremaschi, G.A., Pascual, J., Genaro, 
A.M. and Borda, E.S. (1984) Clin. Exp. Immunol. 58, 
223-228. 
[14] Cremaschi, G.A. and Sterin-Borda, L. (1988) Int. J. Im- 
munopharmacol. 10, 569-578. 
[15] Sterin-Borda, L., Gimeno, M.F. and Gimeno, A.L. (1974) 
Proc. Soc. Exp. Biol. Med. 145, 1151-1157. 
[16] Berridge, M.J., Downes, C.P. and Hanley, M.R. (1982) 
Biochem. J. 206, 587-595. 
[17] Hokin-Neaverson, M. and Sadeghian, K. (1976) J. 
Chromatogr. 120, 502-505. 
[18] Brown, S.L. and Heller Brown, J. (1983) Mol. Pharmacol. 
24, 351-356. 
[19] Gorelik, G., Borda, E., Wald, M. and Sterin-Borda, L. 
(1988) Methods Find. Exp. Clin. Pharmacol. 10, 301-309. 
[20] Brown, J.H. and Brown Master, S. (1984) Fed. Proc. 43, 
2613-2617. 
[21] Brown, J.H., Buxton, I.L. and Brunton, L.L. (1985) Circ. 
Res. 57, 532-537. 
306 
